Weiss, Clifford R., The Hereditary Hemorrhagic Telangiectasia Center for Clinical Excellence, Johns Hopkins School of Medicine, Baltimore, MD, United States
-
Vol. 13, No. 6, Jun 2022 - Case Reports
The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report
Abstract HTML PDF